JP2003048831A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003048831A5 JP2003048831A5 JP2001235519A JP2001235519A JP2003048831A5 JP 2003048831 A5 JP2003048831 A5 JP 2003048831A5 JP 2001235519 A JP2001235519 A JP 2001235519A JP 2001235519 A JP2001235519 A JP 2001235519A JP 2003048831 A5 JP2003048831 A5 JP 2003048831A5
- Authority
- JP
- Japan
- Prior art keywords
- arachidonic acid
- food
- acid
- composition
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 94
- 239000000203 mixture Substances 0.000 description 51
- 229940114079 arachidonic acid Drugs 0.000 description 47
- 235000021342 arachidonic acid Nutrition 0.000 description 47
- 235000013305 food Nutrition 0.000 description 38
- 235000014113 dietary fatty acids Nutrition 0.000 description 29
- 229930195729 fatty acid Natural products 0.000 description 29
- 239000000194 fatty acid Substances 0.000 description 29
- 150000004665 fatty acids Chemical class 0.000 description 29
- 239000000470 constituent Substances 0.000 description 23
- 230000003925 brain function Effects 0.000 description 21
- 208000024891 symptom Diseases 0.000 description 20
- 201000010099 disease Diseases 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 19
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 12
- 230000009471 action Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 206010012289 Dementia Diseases 0.000 description 8
- 150000004667 medium chain fatty acids Chemical group 0.000 description 8
- 208000024827 Alzheimer disease Diseases 0.000 description 7
- 208000027534 Emotional disease Diseases 0.000 description 7
- 208000013677 cerebrovascular dementia Diseases 0.000 description 7
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 7
- 229940090949 docosahexaenoic acid Drugs 0.000 description 7
- 230000013016 learning Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 229930186217 Glycolipid Natural products 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 150000003904 phospholipids Chemical class 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 208000036626 Mental retardation Diseases 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000003449 preventive effect Effects 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 3
- -1 alcohol ester Chemical class 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 208000000044 Amnesia Diseases 0.000 description 2
- 201000006347 Intellectual Disability Diseases 0.000 description 2
- 208000026139 Memory disease Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000006984 memory degeneration Effects 0.000 description 2
- 206010027175 memory impairment Diseases 0.000 description 2
- 208000023060 memory loss Diseases 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 241000235575 Mortierella Species 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000006993 memory improvement Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
Priority Applications (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001235519A JP2003048831A (ja) | 2001-08-02 | 2001-08-02 | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| PCT/JP2002/000671 WO2003013497A1 (en) | 2001-08-02 | 2002-01-29 | Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
| AT02716453T ATE520395T1 (de) | 2001-08-02 | 2002-01-29 | Zusammensetzungen zur prävention oder linderung von zuständen oder erkrankungen, die durch unterfunktion des gehirns verursacht werden |
| DK02716453.2T DK1419768T3 (da) | 2001-08-02 | 2002-01-29 | Præparater med virkning til forebyggelse eller bedring af tilstande eller sygdomme forårsaget af hjernehypofunktion |
| KR1020177026429A KR20170109693A (ko) | 2001-08-02 | 2002-01-29 | 뇌기능 저하에 기인하는 증상이나 질환의 예방 또는 개선 작용을 가지는 조성물 |
| ES02716453T ES2369074T3 (es) | 2001-08-02 | 2002-01-29 | Composiciones que tienen efectos preventivos o mejoradores de síntomas o enfermedades provocados por una hipofunción cerebral. |
| CA2456049A CA2456049C (en) | 2001-08-02 | 2002-01-29 | Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
| KR1020047001544A KR101989390B1 (ko) | 2001-08-02 | 2002-01-29 | 뇌기능 저하에 기인하는 증상이나 질환의 예방 또는 개선작용을 가지는 조성물 |
| CNA200810131360XA CN101336913A (zh) | 2001-08-02 | 2002-01-29 | 具有预防或改善脑功能降低引起的症状或疾病的作用的组合物 |
| CNA028192125A CN1561206A (zh) | 2001-08-02 | 2002-01-29 | 具有预防或改善脑功能降低引起的症状或疾病的作用的组合物 |
| US10/485,456 US10744146B2 (en) | 2001-08-02 | 2002-01-29 | Composition having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
| EP02716453A EP1419768B1 (en) | 2001-08-02 | 2002-01-29 | Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
| PT02716453T PT1419768E (pt) | 2001-08-02 | 2002-01-29 | Composições que têm efeitos de prevenção ou melhoramento de patologias ou doenças causadas por hipofunção cerebral |
| AU2008201045A AU2008201045B2 (en) | 2001-08-02 | 2008-03-05 | Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
| CY20111100859T CY1111808T1 (el) | 2001-08-02 | 2011-09-07 | Συνθεσεις εχουσες αποτελεσματα προληψης ή βελτιωσης καταστασεων ή νοσων που προκαλουνται απο εγκεφαλικη υπολειτουργια |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001235519A JP2003048831A (ja) | 2001-08-02 | 2001-08-02 | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011230136A Division JP5496163B2 (ja) | 2011-10-19 | 2011-10-19 | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003048831A JP2003048831A (ja) | 2003-02-21 |
| JP2003048831A5 true JP2003048831A5 (enExample) | 2010-09-24 |
Family
ID=19066953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001235519A Withdrawn JP2003048831A (ja) | 2001-08-02 | 2001-08-02 | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10744146B2 (enExample) |
| EP (1) | EP1419768B1 (enExample) |
| JP (1) | JP2003048831A (enExample) |
| KR (2) | KR101989390B1 (enExample) |
| CN (2) | CN101336913A (enExample) |
| AT (1) | ATE520395T1 (enExample) |
| AU (1) | AU2008201045B2 (enExample) |
| CA (1) | CA2456049C (enExample) |
| CY (1) | CY1111808T1 (enExample) |
| DK (1) | DK1419768T3 (enExample) |
| ES (1) | ES2369074T3 (enExample) |
| PT (1) | PT1419768E (enExample) |
| WO (1) | WO2003013497A1 (enExample) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070004670A1 (en) * | 1998-07-31 | 2007-01-04 | Richard Wurtman | Compositions containing citicoline, and methods of use thereof |
| US6835750B1 (en) | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| JP2003048831A (ja) | 2001-08-02 | 2003-02-21 | Suntory Ltd | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| WO2004028529A1 (en) * | 2002-09-24 | 2004-04-08 | Suntory Limited | Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person |
| CN101843610A (zh) * | 2003-03-27 | 2010-09-29 | 三得利控股株式会社 | 花生四烯酸在制备具有使超昼夜节律正常化作用的组合物中的用途 |
| AU2004223980B2 (en) | 2003-03-27 | 2010-11-11 | Suntory Holdings Limited | Lipid-improving agent and composition containing lipid-improving agent |
| GB0311081D0 (en) | 2003-05-14 | 2003-06-18 | Btg Internat Limted | Treatment of neurodegenerative conditions |
| GB2442161B (en) * | 2003-08-18 | 2008-05-21 | Btg Int Ltd | Triglycerides |
| GB2442164B (en) * | 2003-08-18 | 2008-05-21 | Btg Int Ltd | Treatment of neurodegenerative conditions |
| FI20060154A7 (fi) * | 2003-08-18 | 2006-05-11 | Btg Int Ltd | Neurogeneratiivisten tilojen hoito |
| GB0319358D0 (en) * | 2003-08-18 | 2003-09-17 | Btg Int Ltd | Treatment of neurodegenerative conditions |
| JP4522075B2 (ja) * | 2003-10-29 | 2010-08-11 | サントリーホールディングス株式会社 | 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| TWI365716B (en) * | 2003-12-02 | 2012-06-11 | Suntory Holdings Ltd | Oil or fat and oil compositions containing phospholipids and a long-chain polyunsaturated fatty acid supply compound, and food using same |
| US20090215896A1 (en) * | 2004-01-19 | 2009-08-27 | Martek Biosciences Corporation | Reelin deficiency or dysfunction and methods related thereto |
| CN1954079B (zh) | 2004-03-01 | 2012-08-08 | 三得利控股株式会社 | 含有作为构成要素的长链高不饱和脂肪酸的磷脂质的制造方法及其应用 |
| CA2575671C (en) | 2004-08-12 | 2013-10-22 | Suntory Limited | Method for polyunsaturated fatty acid production using novel cell preservation technique |
| JP4993852B2 (ja) * | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP2006083136A (ja) * | 2004-09-17 | 2006-03-30 | Suntory Ltd | ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP4849806B2 (ja) | 2005-02-08 | 2012-01-11 | 日本水産株式会社 | 新規な菌体処理方法を用いた高度不飽和脂肪酸の製造方法 |
| US8241868B2 (en) | 2005-02-08 | 2012-08-14 | Nippon Suisan Kaisha, Ltd. | Production of polyunsaturated fatty acids using cell treatment method |
| GB0504362D0 (en) | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Cytokine modulators |
| PT1888081T (pt) * | 2005-05-23 | 2017-03-01 | Massachusetts Inst Technology | Composições contendo pufa e seus métodos de utilização |
| JP5697293B2 (ja) * | 2005-06-30 | 2015-04-08 | サントリーホールディングス株式会社 | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 |
| JP5967855B2 (ja) * | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および／又はうつ症状の改善作用を有する組成物 |
| AU2006299665B2 (en) * | 2005-09-30 | 2012-12-13 | Nestec S.A. | Methods and compositions for improving cognitive function |
| EP1772146A1 (en) * | 2005-10-03 | 2007-04-11 | Neuropharma, S.A. | Polyunsaturated fatty acids as bace inhibitors |
| DE102005058369A1 (de) * | 2005-12-06 | 2007-06-14 | Lts Lohmann Therapie-Systeme Ag | Ungesättigte Fettsäuren als Thrombin-Inhibitoren |
| JP5050195B2 (ja) * | 2006-02-14 | 2012-10-17 | 国立大学法人 岡山大学 | 神経細胞分化誘導剤 |
| KR20090003148A (ko) * | 2006-04-03 | 2009-01-09 | 액세라인크 | 나이와 관련된 기억 손상의 치료를 위한 케톤 생성조성물의 용도 |
| KR101430214B1 (ko) * | 2006-12-28 | 2014-08-18 | 산토리 홀딩스 가부시키가이샤 | 신경 재생제 |
| US8697138B2 (en) | 2007-03-28 | 2014-04-15 | Aker Biomarine As | Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders |
| WO2008117062A1 (en) | 2007-03-28 | 2008-10-02 | Aker Biomarine Asa | Bioeffective krill oil compositions |
| AU2008269989B2 (en) * | 2007-06-29 | 2014-02-27 | Dsm Ip Assets B.V. | Production and purification of esters of polyunsaturated fatty acids |
| JP2009019025A (ja) * | 2007-07-13 | 2009-01-29 | Suntory Ltd | 非ヒト動物の老化又は痴呆に伴う疾患又は症状の改善剤 |
| AU2008282130B2 (en) | 2007-07-31 | 2014-08-21 | Cerecin Inc. | Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |
| US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| EP2303036A1 (en) | 2008-07-03 | 2011-04-06 | Accera, Inc. | Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders |
| US8372812B2 (en) | 2009-02-26 | 2013-02-12 | Aker Biomarine Asa | Phospholipid and protein tablets |
| JP2009219500A (ja) * | 2009-06-22 | 2009-10-01 | Suntory Holdings Ltd | 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP2011136948A (ja) * | 2009-12-28 | 2011-07-14 | Nisshin Oillio Group Ltd | うつ病又はうつ状態の予防又は治療用油脂組成物 |
| AU2014203179C1 (en) | 2013-06-14 | 2017-05-04 | Aker Biomarine Antarctic As | Lipid extraction processes |
| US9549937B2 (en) | 2013-12-05 | 2017-01-24 | Burvia, LLC. | Composition containing phospholipid-DHA and folate |
| US9216199B2 (en) | 2013-12-05 | 2015-12-22 | Buriva, LLC | Nutritional supplement containing phospholipid-DHA derived from eggs |
| US9610302B2 (en) | 2013-12-05 | 2017-04-04 | Buriva, LLC. | Composition containing phospholipid-DHA and B vitamins |
| US9233114B2 (en) | 2013-12-05 | 2016-01-12 | Buriva, LLC | Dietary supplement containing phospholipid-DHA derived from eggs |
| GB201400431D0 (en) | 2014-01-10 | 2014-02-26 | Aker Biomarine As | Phospholipid compositions and their preparation |
| CN106659782B (zh) | 2014-05-23 | 2021-11-09 | 塞尔德克斯医疗公司 | 一种用于嗜酸性粒细胞或肥大细胞相关病症治疗的抗体 |
| JP6095615B2 (ja) * | 2014-07-22 | 2017-03-15 | サントリーホールディングス株式会社 | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 |
| CN114304375A (zh) | 2015-02-11 | 2022-04-12 | 阿克海洋生物南极股份公司 | 脂质组合物 |
| PT3256003T (pt) | 2015-02-11 | 2023-02-15 | Aker Biomarine Antarctic As | Processo de extração de lipídios |
| JP2016172770A (ja) * | 2016-06-29 | 2016-09-29 | サントリーホールディングス株式会社 | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 |
| US10456368B2 (en) | 2016-09-26 | 2019-10-29 | Garrett E. Wdowin | Compositions for mitigating brain trauma and methods thereof |
| CN110747239B (zh) * | 2019-11-26 | 2021-06-22 | 瞿瀚鹏 | 富含Sn-2位ARA的微生物油脂及其制备方法和应用 |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB111282A (en) | 1916-11-10 | Ets De Dion Bouton | Improvements in or relating to Roller Bearings. | |
| US4668704A (en) * | 1982-08-09 | 1987-05-26 | Regents Of The University Of California | Method for protecting and healing gastro-duodenal mucosa and the liver of mammals |
| US4526902A (en) * | 1983-10-24 | 1985-07-02 | Century Laboratories, Inc. | Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions |
| GB8601915D0 (en) | 1986-01-27 | 1986-03-05 | Efamol Ltd | Pharmaceutical compositions |
| JPS63297342A (ja) | 1987-05-28 | 1988-12-05 | Nisshin Oil Mills Ltd:The | 合成油脂ならびにこれを含有する脂肪乳剤輸液および経腸栄養剤 |
| US5198468A (en) * | 1987-06-24 | 1993-03-30 | Efamol Holdings Plc | Essential fatty acid composition |
| GB8714772D0 (en) | 1987-06-24 | 1987-07-29 | Efamol Ltd | Essential fatty acid compositions |
| US5658767A (en) | 1991-01-24 | 1997-08-19 | Martek Corporation | Arachidonic acid and methods for the production and use thereof |
| GB9224809D0 (en) | 1992-11-26 | 1993-01-13 | Scotia Holdings Plc | Schizophrenia |
| GB9300125D0 (en) * | 1993-01-06 | 1993-03-03 | Scotia Holdings Plc | Compositions containing esters of unsaturated fatty acids |
| AU683027B2 (en) * | 1993-01-27 | 1997-10-30 | Scotia Holdings Plc | Triglycerides |
| JP3467794B2 (ja) | 1993-03-09 | 2003-11-17 | 日本油脂株式会社 | 学習能向上剤 |
| WO1994028891A1 (en) | 1993-06-04 | 1994-12-22 | Martek Biosciences Corporation | Method of treating coronary vascular disease using docosahexaenoic acid |
| CA2596241C (en) | 1993-06-09 | 2011-04-19 | Martek Biosciences Corporation | Methods and pharmaceutical compositions useful for treating neurological disorders |
| ES2118629T3 (es) | 1994-10-05 | 1998-09-16 | Milupa Gmbh & Co Kg | Mezcla de grasas conteniendo fosfolipidos con acidos grasos lcp |
| JPH08143454A (ja) | 1994-11-17 | 1996-06-04 | Kanagawa Kagaku Kenkyusho:Kk | 神経成長因子産生増強剤 |
| GB9423625D0 (en) | 1994-11-23 | 1995-01-11 | Scotia Holdings Plc | Fortified fruit juice |
| US5583019A (en) * | 1995-01-24 | 1996-12-10 | Omegatech Inc. | Method for production of arachidonic acid |
| JPH08214891A (ja) | 1995-02-17 | 1996-08-27 | Osaka City | 高度不飽和脂肪酸含有トリグリセリドを含む油脂の製造方法 |
| EP0831805A1 (en) | 1995-06-07 | 1998-04-01 | Martek Biosciences Corporation | Methods for controlling highly unsaturated fatty acid content in various tissues |
| JPH0923817A (ja) | 1995-07-07 | 1997-01-28 | Nisshin Oil Mills Ltd:The | 油脂含有飲食物 |
| JPH0930962A (ja) | 1995-07-21 | 1997-02-04 | Nisshin Oil Mills Ltd:The | 医療用油脂含有組成物 |
| US6200624B1 (en) | 1996-01-26 | 2001-03-13 | Abbott Laboratories | Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids |
| CN1058845C (zh) | 1996-01-31 | 2000-11-29 | 高世虎 | 强化营养豆奶粉 |
| GB9617847D0 (en) | 1996-08-27 | 1996-10-09 | Scotia Holdings Plc | Fatty acid treatment |
| JP4034370B2 (ja) * | 1996-09-27 | 2008-01-16 | 雪印乳業株式会社 | 脳機能改善剤及び栄養組成物 |
| JP4633204B2 (ja) | 1996-10-11 | 2011-02-16 | サントリーホールディングス株式会社 | アラキドン酸含有食用油脂およびそれを含有する食品 |
| JPH10155459A (ja) | 1996-11-27 | 1998-06-16 | Suntory Ltd | アスタキサンチン含有飲食物 |
| US6080787A (en) * | 1997-02-21 | 2000-06-27 | Abbott Laboratories | Methods for reducing the incidence of necrotizing enterocolitis |
| FR2762993B1 (fr) | 1997-05-06 | 1999-08-13 | Inst Rech Biolog Sa | Nouvelle utilisation de phospholipides d'origine animale en therapeutique et/ou dietetique |
| US5902807A (en) * | 1997-05-12 | 1999-05-11 | Antti Haapalinna | Method for the treatment of mental illness in mammals and a composition therefor |
| KR100255868B1 (ko) * | 1997-06-28 | 2000-05-01 | 김영환 | 2의 보수 복소수 곱셈기 |
| EP0893064B1 (fr) | 1997-07-22 | 2003-01-15 | Societe Des Produits Nestle S.A. | Composition lipidique pour formule infantile et procédé de préparation |
| JP2970804B2 (ja) | 1997-07-23 | 1999-11-02 | 株式会社フジクラ | 難燃性シート |
| US6225444B1 (en) * | 1998-02-10 | 2001-05-01 | Protarga, Inc. | Neuroprotective peptides and uses thereof |
| JP4175698B2 (ja) | 1998-06-19 | 2008-11-05 | サントリー株式会社 | 新規なトリグリセリド及びそれを含む組成物 |
| ES2284286T5 (es) * | 1998-10-15 | 2011-01-03 | Dsm Ip Assets B.V. | Suplementos de pufa. |
| JP2001031586A (ja) | 1999-07-14 | 2001-02-06 | Sunstar Inc | 動脈硬化症及び動脈硬化症に起因する疾患の予防又は治療組成物 |
| GB9916536D0 (en) | 1999-07-14 | 1999-09-15 | Scarista Limited | Nutritional or pharmaceutical compositions |
| GB9923738D0 (en) | 1999-10-07 | 1999-12-08 | Nestle Sa | Nutritional composition |
| US7226916B1 (en) | 2000-05-08 | 2007-06-05 | N.V. Nutricia | Preparation for the prevention and/or treatment of vascular disorders |
| US7208180B2 (en) * | 2000-05-08 | 2007-04-24 | N.V. Nutricia | Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith |
| AU2001269375A1 (en) | 2000-05-08 | 2001-11-20 | Forskarpatent I Syd Ab | Anandamide and structurally related lipids as vanilloid receptor modulators |
| US20020077355A1 (en) | 2000-05-30 | 2002-06-20 | Liao James K. | Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions |
| EP1292288B1 (en) | 2000-06-23 | 2004-09-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury |
| GB0016045D0 (en) * | 2000-06-29 | 2000-08-23 | Laxdale Limited | Therapeutic combinations of fatty acids |
| WO2002019839A1 (en) | 2000-09-07 | 2002-03-14 | University Of Maryland Biotechnology Institute | Use of arachidonic acid for enhanced culturing of fish larvae and broodstock |
| EP1239022B1 (fr) | 2001-03-09 | 2009-05-06 | Societe Des Produits Nestle S.A. | Huile contenant un ou des acide(s) gras polyinsaturé(s) à longue chaîne issus de biomasse, procédé de Préparation, allment, composition nutritionnelle, cosmétique ou pharmaceutique la contenant |
| GB0111282D0 (en) | 2001-05-09 | 2001-06-27 | Laxdale Ltd | Potentiation of therapeutic effects of fatty acids |
| DK1997498T3 (da) | 2001-06-18 | 2012-07-30 | Neptune Technologies & Bioressources Inc | Krillekstrakter til forebyggelse og/eller behandling af kardiovaskulære sygdomme |
| CA2452401C (en) | 2001-07-02 | 2013-02-26 | Suntory Limited | Process for producing fat comprising triglyceride containing highly unsaturated fatty acid |
| JP2003048831A (ja) | 2001-08-02 | 2003-02-21 | Suntory Ltd | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| US20040219208A1 (en) * | 2001-08-03 | 2004-11-04 | Ryu Kawamura | Sustained-release medicines |
| JP2003113120A (ja) | 2001-08-03 | 2003-04-18 | Takeda Chem Ind Ltd | 徐放性医薬 |
| US6689810B2 (en) * | 2001-08-21 | 2004-02-10 | Cellular Sciences, Inc. | Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide |
| EP1501493B1 (en) | 2002-05-03 | 2009-10-07 | Pronova BioPharma Norge AS | Use of epa and dha in secondary prevention of strokes |
| AU2003260967B2 (en) | 2002-09-13 | 2009-12-10 | Suntory Holdings Limited | Process for production of transesterified oils/fats or triglycerides |
| GB0221480D0 (en) | 2002-09-16 | 2002-10-23 | Laxdale Ltd | Treatment of anorexia nervosa (AN) and bulimia |
| WO2004028529A1 (en) | 2002-09-24 | 2004-04-08 | Suntory Limited | Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person |
| CN101843610A (zh) | 2003-03-27 | 2010-09-29 | 三得利控股株式会社 | 花生四烯酸在制备具有使超昼夜节律正常化作用的组合物中的用途 |
| JPWO2004091663A1 (ja) | 2003-04-18 | 2006-07-06 | 協和醗酵工業株式会社 | 神経再生薬 |
| FI20060154A7 (fi) | 2003-08-18 | 2006-05-11 | Btg Int Ltd | Neurogeneratiivisten tilojen hoito |
| IL158552A0 (en) | 2003-10-22 | 2004-05-12 | Enzymotec Ltd | Lipids containing omega-3 fatty acids |
| JP4522075B2 (ja) | 2003-10-29 | 2010-08-11 | サントリーホールディングス株式会社 | 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| US20090215896A1 (en) | 2004-01-19 | 2009-08-27 | Martek Biosciences Corporation | Reelin deficiency or dysfunction and methods related thereto |
| JP4868199B2 (ja) | 2004-09-10 | 2012-02-01 | 学校法人鈴鹿医療科学大学 | サルビアノール酸ｂを有効成分とする神経幹細胞増殖剤 |
| JP4993852B2 (ja) | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP2006083136A (ja) | 2004-09-17 | 2006-03-30 | Suntory Ltd | ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP5697293B2 (ja) | 2005-06-30 | 2015-04-08 | サントリーホールディングス株式会社 | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 |
-
2001
- 2001-08-02 JP JP2001235519A patent/JP2003048831A/ja not_active Withdrawn
-
2002
- 2002-01-29 KR KR1020047001544A patent/KR101989390B1/ko not_active Expired - Lifetime
- 2002-01-29 WO PCT/JP2002/000671 patent/WO2003013497A1/ja not_active Ceased
- 2002-01-29 CA CA2456049A patent/CA2456049C/en not_active Expired - Lifetime
- 2002-01-29 AT AT02716453T patent/ATE520395T1/de active
- 2002-01-29 CN CNA200810131360XA patent/CN101336913A/zh active Pending
- 2002-01-29 ES ES02716453T patent/ES2369074T3/es not_active Expired - Lifetime
- 2002-01-29 DK DK02716453.2T patent/DK1419768T3/da active
- 2002-01-29 EP EP02716453A patent/EP1419768B1/en not_active Revoked
- 2002-01-29 US US10/485,456 patent/US10744146B2/en not_active Expired - Fee Related
- 2002-01-29 KR KR1020177026429A patent/KR20170109693A/ko not_active Ceased
- 2002-01-29 CN CNA028192125A patent/CN1561206A/zh active Pending
- 2002-01-29 PT PT02716453T patent/PT1419768E/pt unknown
-
2008
- 2008-03-05 AU AU2008201045A patent/AU2008201045B2/en not_active Expired
-
2011
- 2011-09-07 CY CY20111100859T patent/CY1111808T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003048831A5 (enExample) | ||
| CA2456049A1 (en) | Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction | |
| CA2499902A1 (en) | Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person | |
| KR101468191B1 (ko) | 인지 기능의 개선을 위한 글라이세로인지질 | |
| JP6092843B2 (ja) | 神経障害の治療用組成物 | |
| JPH0232017A (ja) | 精神分裂症および／または関連した晩発性運動障害の治療のための薬剤を製造する方法 | |
| EP2279667A1 (en) | Vegetable and marine oil or fat compositions enriched with DHA or EPA and C18 or higher fatty acid | |
| JP5697293B2 (ja) | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 | |
| ME02180B (me) | Supstanca korisna za lečenje poremećaja metabolizma lipida | |
| JP2005528435A (ja) | ポリコサノール組成物、新規供給源からの抽出、およびその使用 | |
| JP2014515928A (ja) | 認知機能減退に対する医療食品 | |
| CA2514524A1 (en) | Use of arachidonic acid for normalization of infradian rhythm | |
| JPWO2007119588A1 (ja) | 脳機能改善剤及び該改善剤を含有する機能性食品 | |
| RU2008103361A (ru) | Композиции, улучшающие пониженную дневную активность и/или депрессивные симптомы | |
| WO2002100393A1 (fr) | Compositions destinees a ameliorer les troubles de manque d'attention/d'hyperactivite | |
| JP2013198444A (ja) | 長命草及び魚介油を含む組成物 | |
| JP5099808B2 (ja) | 脂質代謝改善用組成物 | |
| AU2004215531B2 (en) | Process for producing powdered composition containing highly unsaturated fatty acid esters of ascorbic acid and powdered composition containing esters | |
| TWI669062B (zh) | Composition containing high amounts of sesamin | |
| JPH07255417A (ja) | 機能性健康食品 | |
| JPH0670746A (ja) | ドコサヘキサエン酸を含む食酢 | |
| JP7157743B2 (ja) | ケトン体生成促進剤 | |
| JP2016172770A (ja) | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 | |
| AU2015293608A1 (en) | Nutritional compositions containing phosphatidylserine powder | |
| JP5479696B2 (ja) | 生体内のプラスマローゲン増加剤 |